153 related items for PubMed ID: 15480902
1. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
Suzuki T, Yamamoto T, Ohura M, Fujigaki Y, Yonemura K, Kimura M, Hishida A.
Clin Exp Nephrol; 2004 Sep; 8(3):243-9. PubMed ID: 15480902
[Abstract] [Full Text] [Related]
2. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[Abstract] [Full Text] [Related]
3. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[Abstract] [Full Text] [Related]
4. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
Medicina (B Aires); 2007 Sep; 67(5):445-50. PubMed ID: 18051227
[Abstract] [Full Text] [Related]
5. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
[Abstract] [Full Text] [Related]
6. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
Kobayashi Y, Fujii K, Hiki Y, Tateno S.
Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
[Abstract] [Full Text] [Related]
7. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A, Hiramatsu M, Adachi N, Karashima S, Hattori S, Matsuda I.
Int J Pediatr Nephrol; 1985 Oct; 6(3):205-8. PubMed ID: 4055239
[Abstract] [Full Text] [Related]
8. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[Abstract] [Full Text] [Related]
9. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
Lai KN, Lai FM, Ho CP, Chan KW.
Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
[Abstract] [Full Text] [Related]
10. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
J Nephrol; 2009 Oct; 22(3):387-96. PubMed ID: 19557716
[Abstract] [Full Text] [Related]
11. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[Abstract] [Full Text] [Related]
12. [Effects of steroid therapy in IgA nephropathy].
Ohashi T, Shimokawahara H, Fukumoto M, Azuma K, Uchida Y, Tokuda Y, Ito H, Yasumoto Y, Yamashita W, Harada R.
Fukuoka Igaku Zasshi; 1992 May; 83(5):209-15. PubMed ID: 1612550
[Abstract] [Full Text] [Related]
13. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[Abstract] [Full Text] [Related]
14. Treatment of vasculitic IgA nephropathy.
Harper L, Ferreira MA, Howie AJ, Savage CO, Richards NT, Michael J, Adu D.
J Nephrol; 2000 Jan; 13(5):360-6. PubMed ID: 11063140
[Abstract] [Full Text] [Related]
15. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
Suzuki S, Joh K.
Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
[Abstract] [Full Text] [Related]
16. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyana M, Tateno S.
Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
[No Abstract] [Full Text] [Related]
17. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[Abstract] [Full Text] [Related]
18. The impact of sex in primary glomerulonephritis.
Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[Abstract] [Full Text] [Related]
19. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R, Kobayashi S, Saigusa T, Namikoshi T, Yamada M, Hemmi N, Imakiire T, Kikuchi Y, Suzuki S, Miura S.
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[Abstract] [Full Text] [Related]
20. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF, Júnior GB, Barros FA, Sousa DC, Franco LM, Patrocínio RM.
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
